Your browser doesn't support javascript.
Multiplexable and Biocomputational Virus Detection by CRISPR-Cas9-Mediated Strand Displacement.
Márquez-Costa, Rosa; Montagud-Martínez, Roser; Marqués, María-Carmen; Albert, Eliseo; Navarro, David; Daròs, José-Antonio; Ruiz, Raúl; Rodrigo, Guillermo.
  • Márquez-Costa R; Institute for Integrative Systems Biology (I2SysBio), CSIC - University of Valencia, 46980 Paterna, Spain.
  • Montagud-Martínez R; Institute for Integrative Systems Biology (I2SysBio), CSIC - University of Valencia, 46980 Paterna, Spain.
  • Marqués MC; Institute for Integrative Systems Biology (I2SysBio), CSIC - University of Valencia, 46980 Paterna, Spain.
  • Albert E; Microbiology Service, Clinic University Hospital, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.
  • Navarro D; Microbiology Service, Clinic University Hospital, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.
  • Daròs JA; Department of Microbiology, School of Medicine, University of Valencia, 46010 Valencia, Spain.
  • Ruiz R; Instituto de Biología Molecular y Celular de Plantas (IBMCP), CSIC - Universitat Politècnica de València, 46022 Valencia, Spain.
  • Rodrigo G; Institute for Integrative Systems Biology (I2SysBio), CSIC - University of Valencia, 46980 Paterna, Spain.
Anal Chem ; 95(25): 9564-9574, 2023 06 27.
Article in English | MEDLINE | ID: covidwho-2324755
ABSTRACT
Recurrent disease outbreaks caused by different viruses, including the novel respiratory virus SARS-CoV-2, are challenging our society at a global scale; so versatile virus detection methods would enable a calculated and faster response. Here, we present a novel nucleic acid detection strategy based on CRISPR-Cas9, whose mode of action relies on strand displacement rather than on collateral catalysis, using the Streptococcus pyogenes Cas9 nuclease. Given a preamplification process, a suitable molecular beacon interacts with the ternary CRISPR complex upon targeting to produce a fluorescent signal. We show that SARS-CoV-2 DNA amplicons generated from patient samples can be detected with CRISPR-Cas9. We also show that CRISPR-Cas9 allows the simultaneous detection of different DNA amplicons with the same nuclease, either to detect different SARS-CoV-2 regions or different respiratory viruses. Furthermore, we demonstrate that engineered DNA logic circuits can process different SARS-CoV-2 signals detected by the CRISPR complexes. Collectively, this CRISPR-Cas9 R-loop usage for the molecular beacon opening (COLUMBO) platform allows a multiplexed detection in a single tube, complements the existing CRISPR-based methods, and displays diagnostic and biocomputing potential.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: CRISPR-Cas Systems / COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: Anal Chem Year: 2023 Document Type: Article Affiliation country: Acs.analchem.3c01041

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: CRISPR-Cas Systems / COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: Anal Chem Year: 2023 Document Type: Article Affiliation country: Acs.analchem.3c01041